| Literature DB >> 31449296 |
Rachel Grashow1,2, Marc G Weisskopf1,2,3, Karen K Miller2,4,5, David M Nathan2,6,7, Ross Zafonte2,8,9,10, Frank E Speizer1,2,11, Theodore K Courtney1,2,3, Aaron Baggish2,12, Herman A Taylor2,13, Alvaro Pascual-Leone2,14, Lee M Nadler2,15, Andrea L Roberts1.
Abstract
Importance: Small studies suggest that head trauma in men may be associated with low testosterone levels and sexual dysfunction through mechanisms that likely include hypopituitarism secondary to ischemic injury and pituitary axonal tract damage. Athletes in contact sports may be at risk for pituitary insufficiencies or erectile dysfunction (ED) because of the high number of head traumas experienced during their careers. Whether multiple symptomatic concussive events are associated with later indicators of low testosterone levels and ED is unknown. Objective: To explore the associations between concussion symptom history and participant-reported indicators of low testosterone levels and ED. Design, Setting, and Participants: This cross-sectional study of former professional US-style football players was conducted in Boston, Massachusetts, from January 2015 to March 2017. Surveys on past football exposures, demographic factors, and current health conditions were sent via electronic and postal mail to participants within and outside of the United States. Analyses were conducted in Boston, Massachusetts; the data analysis began in March 2018 and additional analyses were performed through June 2019. Of the 13 720 male former players eligible to enroll who were contacted, 3506 (25.6%) responded. Exposures: Concussion symptom score was calculated by summing the frequency with which participants reported 10 symptoms, such as loss of consciousness, disorientation, nausea, memory problems, and dizziness, at the time of football-related head injury. Main Outcomes and Measures: Self-reported recommendations or prescriptions for low testosterone or ED medication served as indicators for testosterone insufficiency and ED.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31449296 PMCID: PMC6714010 DOI: 10.1001/jamaneurol.2019.2664
Source DB: PubMed Journal: JAMA Neurol ISSN: 2168-6149 Impact factor: 18.302
Demographic, Football, and Current Health Factors by Concussion Symptom Quartile for 3409 Participants
| Quartile (Concussion Score Range) | Concussion Symptom Quartile, No. (%) | |||
|---|---|---|---|---|
| 1 (0.0-10.5) | 2 (10.5-23.0) | 3 (23.5-43.5) | 4 (43.5-130.0) | |
| No. | 853 (25.0) | 852 (25.0) | 852 (25.0) | 852 (25.0) |
| Age, y | ||||
| 21-40 | 202 (23.7) | 198 (23.2) | 228 (26.8) | 240 (28.2) |
| 41-60 | 308 (36.1) | 341 (40.0) | 398 (46.7) | 416 (48.8) |
| >60 | 343 (40.2) | 313 (36.7) | 226 (26.5) | 196 (23.0) |
| Race/ethnicity | ||||
| Black | 310 (36.6) | 286 (34.2) | 347 (41.2) | 331 (39.1) |
| White | 514 (60.8) | 534 (63.9) | 479 (56.8) | 475 (56.1) |
| Other | 22 (2.6) | 16 (1.9) | 17 (2.0) | 40 (4.7) |
| BMI while playing professional football | ||||
| <25.0 | 63 (7.4) | 36 (4.2) | 49 (5.8) | 39 (4.6) |
| 25.0-30.0 | 427 (50.1) | 404 (47.4) | 379 (44.5) | 322 (37.8) |
| >30.0 | 363 (42.6) | 412 (48.4) | 423 (49.6) | 491 (57.6) |
| Professional use of PED | 87 (10.2) | 99 (11.6) | 135 (15.8) | 229 (26.9) |
| Position | ||||
| Defensive back | 117 (13.7) | 118 (13.8) | 142 (16.7) | 122 (14.3) |
| Defensive line | 104 (12.2) | 83 (9.7) | 82 (9.6) | 100 (11.7) |
| Kicker/punter | 61 (7.2) | 23 (2.7) | 14 (1.6) | 6 (0.7) |
| Linebacker | 81 (9.5) | 79 (9.3) | 86 (10.1) | 113 (13.3) |
| Offensive line | 137 (16.1) | 179 (21.0) | 155 (18.2) | 157 (18.4) |
| Quarterback | 51 (6.0) | 58 (6.8) | 36 (4.2) | 18 (2.1) |
| Running back | 70 (8.2) | 68 (8.0) | 87 (10.2) | 94 (11.0) |
| Special teams only | 3 (0.4) | 10 (1.2) | 8 (0.9) | 6 (0.7) |
| Special speed | 20 (2.3) | 34 (4.0) | 43 (5.0) | 37 (4.3) |
| Special strength | 36 (4.2) | 49 (5.8) | 48 (5.6) | 56 (6.6) |
| Tight end | 59 (6.9) | 64 (7.5) | 68 (8.0) | 71 (8.3) |
| Wide receiver | 114 (13.4) | 87 (10.2) | 83 (9.7) | 72 (8.5) |
| Current health-related factors | ||||
| Hypertension | 322 (37.7) | 306 (35.9) | 326 (38.3) | 329 (38.6) |
| High cholesterol levels | 272 (31.9) | 289 (33.9) | 309 (36.3) | 303 (35.6) |
| Diabetes | 60 (7.0) | 92 (10.8) | 76 (8.9) | 72 (8.5) |
| Heart condition | 160 (18.8) | 170 (20.0) | 155 (18.2) | 152 (17.8) |
| Prescription pain medication | 127 (14.9) | 203 (23.8) | 280 (32.9) | 360 (42.3) |
| Prostate or testicular cancer | 33 (3.9) | 42 (4.9) | 24 (2.8) | 33 (3.9) |
| Sleep apnea | 127 (14.9) | 178 (20.9) | 198 (23.2) | 257 (30.2) |
| Current BMI | ||||
| <25.0 | 60 (7.0) | 46 (5.4) | 52 (6.1) | 20 (2.3) |
| 25.0-30.0 | 388 (45.5) | 372 (43.7) | 337 (39.6) | 333 (39.1) |
| >30.0 | 401 (47.0) | 429 (50.4) | 457 (53.6) | 494 (58.0) |
| Mood indicators | ||||
| Anxiety only | 28 (3.3) | 42 (4.9) | 68 (8.0) | 98 (11.5) |
| Depression only | 17 (2.0) | 30 (3.5) | 47 (5.5) | 45 (5.3) |
| Depression and anxiety | 26 (3.0) | 68 (8.0) | 113 (13.3) | 262 (30.8) |
| Alcohol drinks per wk | ||||
| None | 268 (31.4) | 270 (31.7) | 253 (29.7) | 271 (31.8) |
| 1-7 | 314 (36.8) | 329 (38.6) | 309 (36.3) | 314 (36.9) |
| 8-14 | 158 (18.5) | 146 (17.1) | 145 (17.0) | 137 (16.1) |
| ≥15 | 99 (11.6) | 101 (11.9) | 134 (15.7) | 122 (14.3) |
Abbreviations: BMI, body mass index; PED, performance-enhancing drugs.
Calculated as weight in kilograms divided by height in meters squared.
Heart condition includes self-reported heart rhythm issues, myocardial infarction, heart failure, or cardiac surgery.
Prevalence of History of Low Testosterone Levels and Erectile Dysfunction Indicators by Demographic, Football, and Current Health Factors for 3409 Participants
| Characteristic | No. | Prevalence of History of Prescription Recommendation by Self-report, No. (%) | |
|---|---|---|---|
| Low Testosterone Levels | Erectile Dysfunction | ||
| All | 611 (18.3) | 755 (22.7) | |
| Age, y | |||
| 21-40 | 868 | 70 (8.2) | 46 (5.4) |
| 41-60 | 1463 | 301 (20.9) | 307 (21.4) |
| >60 | 1078 | 240 (23.1) | 402 (38.6) |
| Race | |||
| Black | 1274 | 210 (16.8) | 280 (22.5) |
| White | 2002 | 373 (19.1) | 454 (23.2) |
| Other | 95 | 23 (24.2) | 14 (15.2) |
| Missing | 38 | 5 (13.5) | 7 (18.9) |
| BMI while playing professional football | |||
| <25.0 | 187 | 33 (17.7) | 36 (19.9) |
| 25.0-30.0 | 1532 | 243 (16.3) | 353 (23.6) |
| >30.0 | 1689 | 334 (20.2) | 365 (22.0) |
| Professional use of PED | |||
| No | 2859 | 471 (16.8) | 608 (21.8) |
| Yes | 550 | 140 (26.1) | 147 (27.3) |
| Hypertension | |||
| No | 2083 | 287 (13.9) | 297 (14.5) |
| Yes | 1283 | 318 (25.5) | 450 (35.9) |
| High cholesterol levels | |||
| No | 2165 | 292 (13.7) | 352 (16.5) |
| Yes | 1173 | 309 (27.0) | 387 (33.6) |
| Diabetes | |||
| No | 3021 | 504 (16.9) | 596 (20.0) |
| Yes | 300 | 95 (32.5) | 136 (46.7) |
| Heart condition | |||
| No | 2772 | 437 (16.0) | 522 (19.2) |
| Yes | 637 | 174 (28.5) | 233 (37.8) |
| Prescription pain medication | |||
| No | 2439 | 328 (13.7) | 415 (17.4) |
| Yes | 970 | 283 (29.9) | 340 (35.7) |
| Prostate or testicular cancer | |||
| No | 3277 | 576 (18) | 686 (21.4) |
| Yes | 132 | 35 (27.1) | 69 (54.3) |
| Sleep apnea | |||
| No | 2582 | 367 (14.5) | 478 (18.8) |
| Yes | 760 | 236 (31.9) | 264 (35.7) |
| Current BMI | |||
| <25.0 | 178 | 16 (9.1) | 32 (18.4) |
| 25.0-30.0 | 1430 | 211 (15.1) | 276 (19.8) |
| >30.0 | 1781 | 383 (22.0) | 442 (25.4) |
| Mood indicators | |||
| No depression or anxiety | 2562 | 357 (14.3) | 479 (19.1) |
| Anxiety only | 236 | 44 (19.0) | 49 (21.2) |
| Depression only | 139 | 36 (26.5) | 43 (31.9) |
| Depression and anxiety | 469 | 174 (37.8) | 184 (40) |
| Alcohol drinks per wk | |||
| None | 1062 | 213 (20.5) | 240 (23.1) |
| 1-7 | 1266 | 210 (17.0) | 266 (21.5) |
| 8-14 | 586 | 97 (17.0) | 128 (22.1) |
| ≥15 | 456 | 85 (19.0) | 111 (24.8) |
Abbreviations: BMI, body mass index; PED, performance-enhancing drugs.
Calculated as weight in kilograms divided by height in meters squared.
Heart condition includes self-reported heart rhythm issues, myocardial infarction, heart failure, or cardiac surgery.
Derived from Patient Health Questionnaire 4.
Low Testosterone Levels or ED Indicators in Association With Established Low Testosterone Levels and ED Risk Factors for 3409 Participants
| Characteristic | Prevalence of History of Prescription Recommendation by Self-report, OR (95% CI) | |
|---|---|---|
| Low Testosterone | ED | |
| Age, y | ||
| 21-40 | 1 [Reference] | 1 [Reference] |
| 41-60 | 2.99 (2.27-3.94) | 4.82 (3.49-6.66) |
| >60 | 3.41 (2.56-4.55) | 12.22 (8.79-16.98) |
| Race/ethnicity | ||
| White | 1 [Reference] | 1 [Reference] |
| Black | 0.97 (0.80-1.17) | 1.4 (1.17-1.69) |
| Other | 1.61 (0.98-2.64) | 0.87 (0.47-1.59) |
| Missing | 0.64 (0.25-1.67) | 0.63 (0.27-1.50) |
| Model 2: hypertension | 1.81 (1.50-2.19) | 2.26 (1.89-2.71) |
| Model 3: high cholesterol levels | 1.96 (1.62-2.37) | 1.69 (1.41-2.02) |
| Model 4: diabetes | 2.04 (1.55-2.69) | 2.66 (2.04-3.45) |
| Model 5: heart condition | 1.73 (1.39-2.15) | 1.64 (1.34-2.01) |
| Model 6: prescription pain medication | 2.53 (2.10-3.05) | 2.3 (1.93-2.75) |
| Model 7: prostate or testicular cancer | 1.31 (0.87-1.97) | 2.54 (1.75-3.69) |
| Model 8: sleep apnea | 2.51 (2.07-3.05) | 2.04 (1.69-2.46) |
| Model 9: current BMI | ||
| <25.0 | 1 [Reference] | 1 [Reference] |
| 25.0-30.0 | 1.93 (1.13-3.32) | 1.35 (0.88-2.06) |
| >30.0 | 3.11 (1.82-5.30) | 1.99 (1.31-3.02) |
| Model 10: mood disorders | ||
| None | 1 [Reference] | 1 [Reference] |
| Anxiety indicators only | 1.63 (1.14-2.33) | 1.59 (1.12-2.26) |
| Depression indicators only | 2.22 (1.48-3.34) | 2.11 (1.41-3.15) |
| Depression and anxiety indicators | 4 (3.19-5.02) | 3.37 (2.67-4.24) |
| Model 11: alcohol drinks per wk | ||
| None | 1 [Reference] | 1 [Reference] |
| 1-7 | 0.84 (0.68-1.05) | 1.03 (0.84-1.27) |
| 8-14 | 0.81 (0.61-1.06) | 0.99 (0.76-1.28) |
| 15+ | 0.94 (0.71-1.26) | 1.27 (0.96-1.67) |
Abbreviations: BMI, body mass index; ED, erectile dysfunction; OR, odds ratio.
P < .001.
Heart condition includes self-reported heart rhythm issues, myocardial infarction, heart failure, or cardiac surgery.
Calculated as weight in kilograms divided by height in meters squared.
P < .05.
P < .01.
Figure. Association Between Concussion Symptom Quartile and Loss of Consciousness With Low Testosterone and Erectile Dysfunction
A and B, The lowest quartile served as the reference for all models. The base model is adjusted for age and race/ethnicity; the football exposure model is further adjusted for body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) while playing professional football, position, and use of performance-enhancing drugs; and the fully adjusted model is further adjusted for current BMI, heart condition, diabetes, high cholesterol levels, hypertension, sleep apnea, use of prescription pain medication, alcohol drinks per week, and a history of testicular or prostate cancer. Linear tests of trend were significant (P < .01).
Sensitivity Analyses for Low Testosterone Levels and Erectile Dysfunction Indicators for Each Quartile of Concussion Symptom Score for 3409 Participants
| Model | No. | Concussion Symptom Quartile | History of Prescription Recommendation, OR (95%) | ||
|---|---|---|---|---|---|
| Low Testosterone Levels | Erectile Dysfunction | Low Testosterone Levels | Erectile Dysfunction | ||
| Model 1: base model | 3334 | 3332 | 1 | 1 [Reference] | 1 [Reference] |
| 2 | 1.62 (1.23-2.15) | 1.49 (1.15-1.92) | |||
| 3 | 1.97 (1.49-2.6) | 1.96 (1.53-2.53) | |||
| 4 | 3.49 (2.68-4.56) | 2.41 (1.87-3.11) | |||
| Model 2: case definition includes only current medication users | 3334 | 3332 | 1 | 1 [Reference] | 1 [Reference] |
| 2 | 1.67 (1.10-2.56) | 1.21 (0.88-1.67) | |||
| 3 | 1.93 (1.26-2.94) | 1.65 (1.21-2.24) | |||
| 4 | 3.02 (2.02-4.5) | 1.62 (1.18-2.24) | |||
| Model 3: restricted to men ≤50 y | 1460 | 1457 | 1 | 1 [Reference] | 1 [Reference] |
| 2 | 1.41 (0.84-2.38) | 1.69 (0.90-3.18) | |||
| 3 | 1.72 (1.05-2.83) | 2.75 (1.53-4.93) | |||
| 4 | 2.92 (1.83-4.66) | 3.29 (1.85-5.85) | |||
| Model 4: men who last played ≥20 y prior | 1953 | 1953 | 1 | 1 [Reference] | 1 [Reference] |
| 2 | 1.57 (1.14-2.17) | 1.48 (1.12-1.95) | |||
| 3 | 1.76 (1.27-2.44) | 1.79 (1.35-2.38) | |||
| 4 | 3.08 (2.24-4.24) | 2.09 (1.56-2.80) | |||
| Model 5: fully adjusted including mood disorders | 3334 | 3332 | 1 | 1 [Reference] | 1 [Reference] |
| 2 | 1.33 (0.99-1.78) | 1.19 (0.91-1.56) | |||
| 3 | 1.41 (1.05-1. 90) | 1.43 (1.09-1.88) | |||
| 4 | 1.89 (1.39-2.55) | 1.36 (1.02-1.83) | |||
| Model 6: missing imputed as no | 3409 | 3409 | 1 | 1 [Reference] | 1 [Reference] |
| 2 | 1.61 (1.22-2.13) | 1.48 (1.15-1.91) | |||
| 3 | 1.91 (1.45-2.52) | 1.96 (1.52-2.52) | |||
| 4 | 3.43 (2.63-4.48) | 2.34 (1.82-3.02) | |||
| Model 7: missing imputed as yes | 3409 | 3409 | 1 | 1 [Reference] | 1 [Reference] |
| 2 | 1.67 (1.29-2.17) | 1.51 (1.18-1.92) | |||
| 3 | 2 (1.54-2.60) | 1.93 (1.52-2.46) | |||
| 4 | 3.37 (2.61-4.34) | 2.46 (1.92-3.14) | |||
| Model 8: inverse probability weighted | 3334 | 3332 | 1 | 1 [Reference] | 1 [Reference] |
| 2 | 1.40 (1.04-1.89) | 1.34 (1.01-1.77) | |||
| 3 | 1.50 (1.11-2.03) | 1.65 (1.25-2.19) | |||
| 4 | 2.44 (1.82-3.29) | 1.90 (1.43-2.54) | |||
Abbreviation: OR, odds ratio.
Adjusted for age and race.
P < .01.
P < .001.
P < .05.
Adjusted for age, race, professional body mass index (calculated as weight in kilograms divided by height in meters squared), position, use of performance-enhancing drugs, current body mass index, heart condition (eg, heart rhythm issues, myocardial infarction, heart failure, or cardiac surgery), diabetes, high cholesterol levels, hypertension, sleep apnea, alcohol beverages per week, use of prescription pain medication, and history of testicular or prostate cancer.